4d Molecular Therapeutics Inc (FDMT) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
4d Molecular Therapeutics Inc   (NASDAQ: FDMT)

4d Molecular Therapeutics Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FDMT Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 0 % 71.11 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 95.89 % 73.3 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 70.97 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 99.97 % 20.77 % 18.99 % 20.49 %
EBITDA Margin (Q2 TTM) -107.29 % 26.4 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. --85314.69 % 22.79 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -2037.16 % 11.42 % 16.58 % 16.05 %
Operating Margin (Q2 TTM) -214.24 % 15.3 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. --102464.45 % 6.03 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 7.52 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -115.47 % 14 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 9.88 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -1929.01 % 2.76 % 8.15 % 11.42 %
Net Margin (Q2 TTM) -194.74 % 10.35 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. - 6.58 % 6.08 % 10.8 %



Business Segment Profit Margin
 
United States
  Explore United States Segment  -
JP
  Explore JP Segment  -
Collaboration and License Revenue
  Explore Collaboration and License Revenue Segment  -